Director, Global Product Strategy - Lung Cancer Therapies

BioNTech•Berkeley Heights, NJ

About The Position

We are seeking a strategic, science-driven leader to join our Global Product Strategy team as Director, Lung Cancer Portfolio reports to VP, Lung Cancer Therapies. This position plays a pivotal role in shaping the future of one of our most commercially and scientifically important oncology indications. The role will focus heavily on new product planning and early commercial strategy, partnering closely with R&D, clinical, medical, and regulatory teams to inform development decisions and prepare the path to launch. As part of a growing commercial organization with presence in the US and Germany, this position requires hands-on leadership, deep oncology market insight, and a strong understanding of how to position early assets for future success in a competitive global environment. This is a critical value driver for the company, and the role offers the opportunity to influence the strategic direction of a high-priority solid tumor program with global potential.

Requirements

A minimum of 8 years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles
Strong track record in solid tumors, ideally with direct or adjacent lung cancer experience
Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy
Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development
Demonstrated understanding of the US oncology landscape and stakeholder needs; experience & understanding with EU and other major markets
Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment
Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies

Nice To Haves

Advanced degree (PhD, PharmD, MD, or MBA) strongly preferred

Responsibilities

Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy
Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability
Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions
Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement
Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts
Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership
Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

Benefits

Medical, Dental and Vision Insurance
Life, AD&D, Critical Illness Insurance
Pre-tax HSA & FSA, DCRA Spending Accounts
Employee Assistance & Concierge Program (EAP) available 24/7
Parental and Childbirth Leave & Family Planning Assistance
Sitterstream: Virtual Tutoring & Childcare Membership
Paid Time Off: Vacation, Sick, Bereavement, Holidays (including Floating) & Year-End U.S. Shutdown.
401(K) Plan with Company Match
Tuition Reimbursement & Student Loan Assistance Programs
Wellbeing Incentive Platforms & Incentives
Professional Development Programs
Commuting Allowance and subsidized parking
Discounted Home, Auto & Pet Insurance